JPS6330902B2 - - Google Patents
Info
- Publication number
- JPS6330902B2 JPS6330902B2 JP18395180A JP18395180A JPS6330902B2 JP S6330902 B2 JPS6330902 B2 JP S6330902B2 JP 18395180 A JP18395180 A JP 18395180A JP 18395180 A JP18395180 A JP 18395180A JP S6330902 B2 JPS6330902 B2 JP S6330902B2
- Authority
- JP
- Japan
- Prior art keywords
- singlet
- line
- group
- multiplet
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 93
- -1 tetrahydrofurfuryloxy group Chemical group 0.000 claims description 40
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 19
- 125000005843 halogen group Chemical group 0.000 claims description 18
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 125000005336 allyloxy group Chemical group 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 239000002220 antihypertensive agent Substances 0.000 claims description 10
- 229940030600 antihypertensive agent Drugs 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 7
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 6
- 125000004414 alkyl thio group Chemical group 0.000 claims description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- AUNKVOPLEJSFAG-UHFFFAOYSA-N 1-(2-chloro-3-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CC1=CC=CC(OCC(O)CNC(C)(C)COC=2N=NC(NN)=CC=2)=C1Cl AUNKVOPLEJSFAG-UHFFFAOYSA-N 0.000 claims description 2
- QKKASVISXANBAJ-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(2-methoxyethyl)phenoxy]propan-2-ol Chemical compound COCCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 QKKASVISXANBAJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000243251 Hydra Species 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- SUPHJWNJNDOHFC-UHFFFAOYSA-N 1-(2-chloro-5-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)COC=2N=NC(NN)=CC=2)=C1 SUPHJWNJNDOHFC-UHFFFAOYSA-N 0.000 claims 1
- VWAVWOJBDMDRIB-UHFFFAOYSA-N 2-[3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 VWAVWOJBDMDRIB-UHFFFAOYSA-N 0.000 claims 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 description 146
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 140
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 117
- 229960004592 isopropanol Drugs 0.000 description 114
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 108
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 56
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 46
- 239000002904 solvent Substances 0.000 description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 45
- 235000019441 ethanol Nutrition 0.000 description 41
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 38
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 26
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- 239000000047 product Substances 0.000 description 22
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 18
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 16
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 12
- 235000019341 magnesium sulphate Nutrition 0.000 description 12
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 230000000304 vasodilatating effect Effects 0.000 description 7
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000008101 lactose Substances 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 229910000104 sodium hydride Inorganic materials 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 239000002876 beta blocker Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- YTRGNBTVTHPFJM-UHFFFAOYSA-N pyridazin-3-ylhydrazine Chemical class NNC1=CC=CN=N1 YTRGNBTVTHPFJM-UHFFFAOYSA-N 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 208000001871 Tachycardia Diseases 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 229940097320 beta blocking agent Drugs 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 229960005335 propanol Drugs 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 230000006794 tachycardia Effects 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 229940124549 vasodilator Drugs 0.000 description 3
- 239000003071 vasodilator agent Substances 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- UIFGZHMSKUWISH-UHFFFAOYSA-N 1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-amine Chemical compound CC(C)(N)COC1=CC=C(Cl)N=N1 UIFGZHMSKUWISH-UHFFFAOYSA-N 0.000 description 2
- OLNCAXNQBFXZRI-UHFFFAOYSA-N 1-(6-chloropyridazin-3-yl)sulfanyl-2-methylpropan-2-amine Chemical compound CC(C)(N)CSC1=CC=C(Cl)N=N1 OLNCAXNQBFXZRI-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- GUSWJGOYDXFJSI-UHFFFAOYSA-N 3,6-dichloropyridazine Chemical compound ClC1=CC=C(Cl)N=N1 GUSWJGOYDXFJSI-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241001024304 Mino Species 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 241000577218 Phenes Species 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 229960001317 isoprenaline Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- UMFCIIBZHQXRCJ-NSCUHMNNSA-N trans-anol Chemical compound C\C=C\C1=CC=C(O)C=C1 UMFCIIBZHQXRCJ-NSCUHMNNSA-N 0.000 description 2
- SWGZHHCRMZDRSN-BTJKTKAUSA-N (Z)-but-2-enedioic acid 1-phenoxypropan-2-ylhydrazine Chemical compound OC(=O)\C=C/C(O)=O.NNC(C)COC1=CC=CC=C1 SWGZHHCRMZDRSN-BTJKTKAUSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- HRDOJRIZFCHKBQ-UHFFFAOYSA-N 1-(2,3-dimethylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CC1=CC=CC(OCC(O)CNC(C)(C)COC=2N=NC(NN)=CC=2)=C1C HRDOJRIZFCHKBQ-UHFFFAOYSA-N 0.000 description 1
- AONILFNRTBNRGO-UHFFFAOYSA-N 1-(2,5-dimethylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CC1=CC=C(C)C(OCC(O)CNC(C)(C)COC=2N=NC(NN)=CC=2)=C1 AONILFNRTBNRGO-UHFFFAOYSA-N 0.000 description 1
- HYASBVAVHDNGGP-UHFFFAOYSA-N 1-(2-bromo-3-methylphenoxy)-3-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CC1=CC=CC(OCC(O)CNC(C)(C)COC=2N=NC(Cl)=CC=2)=C1Br HYASBVAVHDNGGP-UHFFFAOYSA-N 0.000 description 1
- VGYFWAIFMAAJMC-UHFFFAOYSA-N 1-(2-chloro-3-methylphenoxy)-3-[1-(6-hydrazinylpyridazin-3-yl)oxypropan-2-ylamino]propan-2-ol Chemical compound C=1C=CC(C)=C(Cl)C=1OCC(O)CNC(C)COC1=CC=C(NN)N=N1 VGYFWAIFMAAJMC-UHFFFAOYSA-N 0.000 description 1
- YSZKUNRXYOLPPS-UHFFFAOYSA-N 1-(2-chloro-3-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)sulfanyl-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CC1=CC=CC(OCC(O)CNC(C)(C)CSC=2N=NC(NN)=CC=2)=C1Cl YSZKUNRXYOLPPS-UHFFFAOYSA-N 0.000 description 1
- PCQGZGURXCEFBV-UHFFFAOYSA-N 1-(2-chloro-5-methoxyphenoxy)-3-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound COC1=CC=C(Cl)C(OCC(O)CNC(C)(C)COC=2N=NC(Cl)=CC=2)=C1 PCQGZGURXCEFBV-UHFFFAOYSA-N 0.000 description 1
- QGAXHFWCKMGKNL-UHFFFAOYSA-N 1-(2-chloro-5-methoxyphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.COC1=CC=C(Cl)C(OCC(O)CNC(C)(C)COC=2N=NC(NN)=CC=2)=C1 QGAXHFWCKMGKNL-UHFFFAOYSA-N 0.000 description 1
- WWAXMOQOOVTLCF-UHFFFAOYSA-N 1-(2-chloro-5-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)sulfanyl-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)CSC=2N=NC(NN)=CC=2)=C1 WWAXMOQOOVTLCF-UHFFFAOYSA-N 0.000 description 1
- YOFVFAVBWJVHLC-UHFFFAOYSA-N 1-(2-chloro-5-methylphenoxy)-3-[[2-methyl-1-[6-(2-propan-2-ylidenehydrazinyl)pyridazin-3-yl]oxypropan-2-yl]amino]propan-2-ol Chemical compound N1=NC(NN=C(C)C)=CC=C1OCC(C)(C)NCC(O)COC1=CC(C)=CC=C1Cl YOFVFAVBWJVHLC-UHFFFAOYSA-N 0.000 description 1
- YWCYRUFXQJPPAD-UHFFFAOYSA-N 1-(2-chlorophenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound C=1C=CC=C(Cl)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 YWCYRUFXQJPPAD-UHFFFAOYSA-N 0.000 description 1
- REUGULAFJKTUKB-UHFFFAOYSA-N 1-(2-chlorophenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)sulfanyl-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound C=1C=CC=C(Cl)C=1OCC(O)CNC(C)(C)CSC1=CC=C(NN)N=N1 REUGULAFJKTUKB-UHFFFAOYSA-N 0.000 description 1
- DMBYDPXTNYQZAC-UHFFFAOYSA-N 1-(2-ethylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 DMBYDPXTNYQZAC-UHFFFAOYSA-N 0.000 description 1
- LEFHPPWRMOILLJ-UHFFFAOYSA-N 1-(3-chloro-2-ethylphenoxy)-3-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCC1=C(Cl)C=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(Cl)N=N1 LEFHPPWRMOILLJ-UHFFFAOYSA-N 0.000 description 1
- SGDWSVHSIAQPSJ-UHFFFAOYSA-N 1-(3-chloro-2-ethylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCC1=C(Cl)C=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 SGDWSVHSIAQPSJ-UHFFFAOYSA-N 0.000 description 1
- MPJQVVPOGKUPJA-UHFFFAOYSA-N 1-(3-chloro-2-methylphenoxy)-3-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CC1=C(Cl)C=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(Cl)N=N1 MPJQVVPOGKUPJA-UHFFFAOYSA-N 0.000 description 1
- BTDYWMBXFVXPAO-UHFFFAOYSA-N 1-(3-chloro-2-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CC1=C(Cl)C=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 BTDYWMBXFVXPAO-UHFFFAOYSA-N 0.000 description 1
- VMTITYSEWQFLGQ-UHFFFAOYSA-N 1-(5-chloro-2-methylphenoxy)-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CC1=CC=C(Cl)C=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 VMTITYSEWQFLGQ-UHFFFAOYSA-N 0.000 description 1
- SYGLWDLQSMXGKZ-UHFFFAOYSA-N 1-(6-chloropyridazin-3-yl)oxypropan-2-amine Chemical compound CC(N)COC1=CC=C(Cl)N=N1 SYGLWDLQSMXGKZ-UHFFFAOYSA-N 0.000 description 1
- YAHCYAKZRIMDRX-UHFFFAOYSA-N 1-(6-chloropyridazin-3-yl)oxypropan-2-amine;hydrochloride Chemical compound Cl.CC(N)COC1=CC=C(Cl)N=N1 YAHCYAKZRIMDRX-UHFFFAOYSA-N 0.000 description 1
- FGJVFMHAUOTKMI-UHFFFAOYSA-N 1-(6-chloropyridazin-3-yl)sulfanylpropan-2-amine Chemical compound CC(N)CSC1=CC=C(Cl)N=N1 FGJVFMHAUOTKMI-UHFFFAOYSA-N 0.000 description 1
- GUOPJJCGZYIALN-UHFFFAOYSA-N 1-[1-(6-chloropyridazin-3-yl)oxypropan-2-ylamino]-3-(2-methoxyphenoxy)propan-2-ol Chemical compound COC1=CC=CC=C1OCC(O)CNC(C)COC1=CC=C(Cl)N=N1 GUOPJJCGZYIALN-UHFFFAOYSA-N 0.000 description 1
- FHQOFTVOYCSMNR-UHFFFAOYSA-N 1-[1-(6-chloropyridazin-3-yl)oxypropan-2-ylamino]-3-[2-(2-methoxyethyl)phenoxy]propan-2-ol Chemical compound COCCC1=CC=CC=C1OCC(O)CNC(C)COC1=CC=C(Cl)N=N1 FHQOFTVOYCSMNR-UHFFFAOYSA-N 0.000 description 1
- XZKXRXOXOZJGCT-UHFFFAOYSA-N 1-[1-(6-hydrazinylpyridazin-3-yl)oxypropan-2-ylamino]-3-[2-(2-methoxyethoxy)phenoxy]propan-2-ol Chemical compound COCCOC1=CC=CC=C1OCC(O)CNC(C)COC1=CC=C(NN)N=N1 XZKXRXOXOZJGCT-UHFFFAOYSA-N 0.000 description 1
- BWRLCOYUMOORAT-UHFFFAOYSA-N 1-[1-(6-hydrazinylpyridazin-3-yl)oxypropan-2-ylamino]-3-[2-(2-methoxyethyl)phenoxy]propan-2-ol Chemical compound COCCC1=CC=CC=C1OCC(O)CNC(C)COC1=CC=C(NN)N=N1 BWRLCOYUMOORAT-UHFFFAOYSA-N 0.000 description 1
- QDUHLKPHCVZAGD-UHFFFAOYSA-N 1-[2-(2-ethoxyethyl)phenoxy]-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCOCCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 QDUHLKPHCVZAGD-UHFFFAOYSA-N 0.000 description 1
- SPPWCNZBLLBBFX-UHFFFAOYSA-N 1-[2-(6-chloropyridazin-3-yl)oxyethylamino]-3-phenoxypropan-2-ol Chemical compound C=1C=CC=CC=1OCC(O)CNCCOC1=CC=C(Cl)N=N1 SPPWCNZBLLBBFX-UHFFFAOYSA-N 0.000 description 1
- SFWMTIZFGGJJGF-UHFFFAOYSA-N 1-[2-(ethoxymethoxy)phenoxy]-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCOCOC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 SFWMTIZFGGJJGF-UHFFFAOYSA-N 0.000 description 1
- UNOPJHVPURLRRP-UHFFFAOYSA-N 1-[2-(ethoxymethyl)phenoxy]-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol Chemical compound CCOCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 UNOPJHVPURLRRP-UHFFFAOYSA-N 0.000 description 1
- RRTMUGSFXOVEHF-UHFFFAOYSA-N 1-[2-(ethoxymethyl)phenoxy]-3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]propan-2-ol;hydrochloride Chemical compound Cl.CCOCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 RRTMUGSFXOVEHF-UHFFFAOYSA-N 0.000 description 1
- JRUSHPDKXNVEIW-UHFFFAOYSA-N 1-[[1-(6-bromopyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-(2-chloro-5-methylphenoxy)propan-2-ol Chemical compound CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)COC=2N=NC(Br)=CC=2)=C1 JRUSHPDKXNVEIW-UHFFFAOYSA-N 0.000 description 1
- OICYZUCXWNZUNF-UHFFFAOYSA-N 1-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(ethoxymethyl)phenoxy]propan-2-ol Chemical compound CCOCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(Cl)N=N1 OICYZUCXWNZUNF-UHFFFAOYSA-N 0.000 description 1
- BRNHBVLYHPQYGA-UHFFFAOYSA-N 1-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(trifluoromethyl)phenoxy]propan-2-ol Chemical compound C=1C=CC=C(C(F)(F)F)C=1OCC(O)CNC(C)(C)COC1=CC=C(Cl)N=N1 BRNHBVLYHPQYGA-UHFFFAOYSA-N 0.000 description 1
- UTUGBLIBOWGHMQ-UHFFFAOYSA-N 1-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-phenoxypropan-2-ol Chemical compound C=1C=CC=CC=1OCC(O)CNC(C)(C)COC1=CC=C(Cl)N=N1 UTUGBLIBOWGHMQ-UHFFFAOYSA-N 0.000 description 1
- JHLRMENKFPBNGI-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-(2-phenylmethoxyphenoxy)propan-2-ol hydrochloride Chemical compound Cl.C=1C=CC=C(OCC=2C=CC=CC=2)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 JHLRMENKFPBNGI-UHFFFAOYSA-N 0.000 description 1
- MHIRMNFFCSFICW-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-(2-propylphenoxy)propan-2-ol Chemical compound CCCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 MHIRMNFFCSFICW-UHFFFAOYSA-N 0.000 description 1
- KCBGXJONYGRTFU-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(2-methoxyethyl)phenoxy]propan-2-ol;hydrochloride Chemical compound Cl.COCCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 KCBGXJONYGRTFU-UHFFFAOYSA-N 0.000 description 1
- AXBSTOXNERQCAG-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(methoxymethyl)phenoxy]propan-2-ol;hydrochloride Chemical compound Cl.COCC1=CC=CC=C1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 AXBSTOXNERQCAG-UHFFFAOYSA-N 0.000 description 1
- RTEGWOLEGDZOFV-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(trifluoromethyl)phenoxy]propan-2-ol Chemical compound C=1C=CC=C(C(F)(F)F)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 RTEGWOLEGDZOFV-UHFFFAOYSA-N 0.000 description 1
- IXVTWJLLWLJOEP-UHFFFAOYSA-N 1-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-3-[2-(trifluoromethyl)phenoxy]propan-2-ol;hydrochloride Chemical compound Cl.C=1C=CC=C(C(F)(F)F)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 IXVTWJLLWLJOEP-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- KLOHRGVQRCCZIF-UHFFFAOYSA-N 2-(2-methoxyethyl)phenol Chemical compound COCCC1=CC=CC=C1O KLOHRGVQRCCZIF-UHFFFAOYSA-N 0.000 description 1
- SGLYMXJNPYLOJE-UHFFFAOYSA-N 2-(6-chloropyridazin-3-yl)oxyethanamine Chemical compound NCCOC1=CC=C(Cl)N=N1 SGLYMXJNPYLOJE-UHFFFAOYSA-N 0.000 description 1
- PQBHXMXGDPJBOU-UHFFFAOYSA-N 2-(6-chloropyridazin-3-yl)oxyethanamine;hydrochloride Chemical compound Cl.NCCOC1=CC=C(Cl)N=N1 PQBHXMXGDPJBOU-UHFFFAOYSA-N 0.000 description 1
- BIJYXIOVXFBJEP-UHFFFAOYSA-N 2-(oxiran-2-ylmethoxy)benzonitrile Chemical compound N#CC1=CC=CC=C1OCC1OC1 BIJYXIOVXFBJEP-UHFFFAOYSA-N 0.000 description 1
- QMMFBOVEATZXFA-UHFFFAOYSA-N 2-[2-hydroxy-3-[2-[6-(2-propan-2-ylidenehydrazinyl)pyridazin-3-yl]oxyethylamino]propoxy]benzonitrile Chemical compound N1=NC(NN=C(C)C)=CC=C1OCCNCC(O)COC1=CC=CC=C1C#N QMMFBOVEATZXFA-UHFFFAOYSA-N 0.000 description 1
- CJITUNRMNIQTAQ-UHFFFAOYSA-N 2-[2-hydroxy-3-[[2-methyl-1-[6-(2-propan-2-ylidenehydrazinyl)pyridazin-3-yl]oxypropan-2-yl]amino]propoxy]benzonitrile Chemical compound N1=NC(NN=C(C)C)=CC=C1OCC(C)(C)NCC(O)COC1=CC=CC=C1C#N CJITUNRMNIQTAQ-UHFFFAOYSA-N 0.000 description 1
- FHAOSYZCOYEUAW-UHFFFAOYSA-N 2-[3-[1-(6-hydrazinylpyridazin-3-yl)oxypropan-2-ylamino]-2-hydroxypropoxy]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1OCC(O)CNC(C)COC1=CC=C(NN)N=N1 FHAOSYZCOYEUAW-UHFFFAOYSA-N 0.000 description 1
- JIQKGZMVTVAYQE-UHFFFAOYSA-N 2-[3-[[1-(6-bromopyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1OCC(O)CNC(C)(C)COC1=CC=C(Br)N=N1 JIQKGZMVTVAYQE-UHFFFAOYSA-N 0.000 description 1
- ZZKWALXPWNTCMG-UHFFFAOYSA-N 2-[3-[[1-(6-chloropyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]-6-methylbenzonitrile Chemical compound CC1=CC=CC(OCC(O)CNC(C)(C)COC=2N=NC(Cl)=CC=2)=C1C#N ZZKWALXPWNTCMG-UHFFFAOYSA-N 0.000 description 1
- MFYGMKCZLSNCFH-UHFFFAOYSA-N 2-[3-[[1-(6-chloropyridazin-3-yl)sulfanyl-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]benzonitrile Chemical compound C=1C=CC=C(C#N)C=1OCC(O)CNC(C)(C)CSC1=CC=C(Cl)N=N1 MFYGMKCZLSNCFH-UHFFFAOYSA-N 0.000 description 1
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 1
- FHIATTMLFDJJKY-UHFFFAOYSA-N 2-hydroxy-1-(4-hydroxyphenyl)-2-phenylethanone Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=C(O)C=C1 FHIATTMLFDJJKY-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- DTSDPBLLTFBLFC-UHFFFAOYSA-N 3-chloro-6-propylsulfanylpyridazine Chemical compound CCCSC1=CC=C(Cl)N=N1 DTSDPBLLTFBLFC-UHFFFAOYSA-N 0.000 description 1
- IBWYHNOFSKJKKY-UHFFFAOYSA-N 3-chloropyridazine Chemical compound ClC1=CC=CN=N1 IBWYHNOFSKJKKY-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- MJAAWFQSYGSPGC-UHFFFAOYSA-N 4-chloro-2-[3-[[1-(6-hydrazinylpyridazin-3-yl)oxy-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]benzonitrile;hydrochloride Chemical compound Cl.C=1C(Cl)=CC=C(C#N)C=1OCC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 MJAAWFQSYGSPGC-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical group CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- PAVAECWWBRCDAW-UHFFFAOYSA-N Cl.CC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 Chemical compound Cl.CC(O)CNC(C)(C)COC1=CC=C(NN)N=N1 PAVAECWWBRCDAW-UHFFFAOYSA-N 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 241001235534 Graphis <ascomycete fungus> Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 125000006351 ethylthiomethyl group Chemical group [H]C([H])([H])C([H])([H])SC([H])([H])* 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000003944 halohydrins Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18395180A JPS57108075A (en) | 1980-12-26 | 1980-12-26 | Hydrazinopyridazine compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18395180A JPS57108075A (en) | 1980-12-26 | 1980-12-26 | Hydrazinopyridazine compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57108075A JPS57108075A (en) | 1982-07-05 |
| JPS6330902B2 true JPS6330902B2 (US07368563-20080506-C00056.png) | 1988-06-21 |
Family
ID=16144666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18395180A Granted JPS57108075A (en) | 1980-12-26 | 1980-12-26 | Hydrazinopyridazine compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57108075A (US07368563-20080506-C00056.png) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01128703U (US07368563-20080506-C00056.png) * | 1988-02-23 | 1989-09-01 | ||
| JPH01153104U (US07368563-20080506-C00056.png) * | 1988-04-15 | 1989-10-23 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4711887A (en) * | 1982-04-23 | 1987-12-08 | Imperial Chemical Industries Plc | Hydrazinopyridazine compounds |
| JPS58225069A (ja) * | 1982-06-23 | 1983-12-27 | Teikoku Hormone Mfg Co Ltd | ヒドラジノピリダジン誘導体 |
-
1980
- 1980-12-26 JP JP18395180A patent/JPS57108075A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01128703U (US07368563-20080506-C00056.png) * | 1988-02-23 | 1989-09-01 | ||
| JPH01153104U (US07368563-20080506-C00056.png) * | 1988-04-15 | 1989-10-23 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57108075A (en) | 1982-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5822119B2 (ja) | ジチオ−ル誘導体 | |
| JP2505728B2 (ja) | 薬物中の１級及び２級アミン官能基のための生物可逆性前駆薬部分としての（アシロキシアルコキシ）カルボニル誘導体 | |
| EP0109866B1 (fr) | Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| DK158460B (da) | Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer | |
| JPS6340784B2 (US07368563-20080506-C00056.png) | ||
| JPS6330902B2 (US07368563-20080506-C00056.png) | ||
| FR2662442A1 (fr) | Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant. | |
| JPS61257952A (ja) | フルオロアリルアミン誘導体類 | |
| FR2534582A1 (fr) | Nouveaux derives de benzofuranne et de benzothiophene, utiles comme agents anti-hyperuricemie et anti-hypertension, et leur procede de fabrication | |
| EP0150139A2 (fr) | Dérivés de l'indole éthénylphénol, leurs sels, procédé de préparation, application à titre de médicaments,et compositions les renfermant | |
| FR2460934A1 (fr) | Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
| LU81554A1 (de) | Alkylthiophenoxyalkylamines | |
| EP0275221B1 (fr) | Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant | |
| JPS6134424B2 (US07368563-20080506-C00056.png) | ||
| US4321398A (en) | Thienyl and benzothienyl-tertiary butylaminophenoxypropanols | |
| FR2632641A1 (fr) | ((aryl-4-piperazinyl-1)-2 ethoxy)-3 p-cymene, les derives ortho, meta, para monosubstitues ou disubstitues sur le noyau phenyle dudit produit, le procede de preparation desdits derives, et les medicaments contenant lesdits composes comme principe actif | |
| JPS6245865B2 (US07368563-20080506-C00056.png) | ||
| JP2535533B2 (ja) | ベンゾジオキソ−ル誘導体 | |
| JP3928057B2 (ja) | クマリン誘導体 | |
| JPS639508B2 (US07368563-20080506-C00056.png) | ||
| JPH0514712B2 (US07368563-20080506-C00056.png) | ||
| HU176501B (en) | Process for preparing new 1-/azacyclic aralkoxy-phenyl/-2- or -3-/bis-aryl-alkyl-amino/-alkanes | |
| JPH0449548B2 (US07368563-20080506-C00056.png) | ||
| JPH1135534A (ja) | フェノキシ酢酸誘導体 | |
| JPH051065A (ja) | キサンチン誘導体 |
